Evidence of trospium’s ability to mitigate cholinergic adverse events related to xanomeline: phase 1 study results

Alan Breier, Stephen K. Brannan, Steven M. Paul, Andrew C. Miller

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Evidence of trospium’s ability to mitigate cholinergic adverse events related to xanomeline: phase 1 study results'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science